Product Introduction
On June 6, 2023, Corheart® 6 received market approval from the National Medical Products Administration (NMPA) of China, with the registration certificate number: National Medical Device Approval 20233120716. The NMPA provided a positive assessment, stating that Corheart® 6 features a “simpler structure, lighter weight, smaller size, and lower power consumption.” They further noted that “in clinical applications, it allows for a smaller surgical incision, promotes faster patient recovery, is suitable for a broader patient population, and can reduce the risk of thrombosis associated with pump heat.”
About Us
HXCOREMED is dedicated to the research and development of high-end innovative medical devices such as Ventricular Assist Systems (VAS) In July 2022, HXCOREMED completed the clinical trial enrollment for product registration. Follow-up has shown that the Corheart 6 has excellent performance in terms of anti-infection, patient recovery, adverse event control and hemocompatibility improvement.
